|
|
|
By Stephen Albert Johnston, Calviri | Calviri has been developing an RNA vaccine to prevent cancer for more than 20 years and repeatedly faced the nearly universal belief that it’s impossible. We’ve learned a number of important lessons along the way that are worth imparting to other vaccine developers. |
|
|
|
|
| Overcoming Limitations To Achieve Uniform Dosing | Case Study | By Tracy Milburn, Cambrex | The formulation for low-dose drugs must ensure that each dosage has an acceptable blend and content uniformity. Choosing the right methods requires expertise across multiple areas of development. |
|
|
|
| Low-Volume Production For Screening High-Value Nanoparticle Materials | Application Note | By Chelsea Cayabyab, Andrew Brown, Grace Tharmarajah, and Anitha Thomas, Precision NanoSystems | A platform that harnesses microfluidic mixing has been demonstrated as a simple, robust, and scalable production method for LNPs encapsulating various types of nucleic acids. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
